A ferroptosis marker peroxidation PRDX3 activity detection kit and detection method
By developing the new compound ENPTD-SH as the substrate for peroxidizing PRDX3, the colored product ENPTD-SO3H was generated, and a system was constructed for detecting the activity of peroxidizing PRDX3, which solved the problem of lack of detection methods in the prior art. Reliable detection of ferrody death processes is achieved.
Patent Information
- Application Number
- CN202410611367.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-16
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-05-16
AI Technical Summary
There is a lack of detection kits and methods for detecting ferrody death marker peroxidized PRDX3 in the prior art, making it difficult to identify the ferrody death process under physiological conditions.
The new compound ENPTD-SH was developed as a specific substrate for peroxidized PRDX3. The colored product ENPTD-SO3H was generated by reaction with ENPTD-SH, and a system and method were constructed for detecting the activity of peroxidized PRDX3, a ferrous death marker was constructed.
Reliable detection of peroxidized PRDX3 enzyme activity is achieved, it is simple and fast in operation, suitable for various samples, filling the gap in the prior art.
Smart Images

Figure CN118496172B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biological detection technology, and in particular relates to a detection kit and a detection method for detecting the activity of ferroptosis marker peroxidase 3 (PRDX3). Background Art
[0002] Ferroptosis is a type of cell death that is strictly and orderly regulated by molecules and is a type of regulated cell death. Ferroptosis is different from apoptosis, programmed necrosis and autophagy. It is a new type of cell death that is iron-dependent and caused by lipid peroxidation. In 2003, Professor Brent Stockwell of Columbia University and others successfully killed oncogenic RAS mutant cells but not normal cells using the small molecule erastin, and in 2008 proved that this was an iron-dependent, non-apoptotic regulated cell death. In 2012, Stockwell officially named this cell death mode ferroptosis. Ferroptosis was confirmed as one of the programmed cell deaths by the Nomenclature Committee on Cell Death (NCCD) in 2018. In recent years, the number of research reports on ferroptosis has surged, and ferroptosis has been shown to play an important role in a variety of biological processes such as development, aging, immunity and cancer.
[0003] Ferroptosis is a regulated cell death pathway driven by the accumulation of phospholipid peroxides. Identifying ferroptosis under physiological conditions has been a challenge due to the lack of specific markers. During ferroptosis, mitochondrial lipid peroxides trigger overoxidation of PRDX3, and this post-translational modification converts Cys thiols to sulfonic acid or sulfonic acid. Once overoxidized, PRDX3 is transported from mitochondria to the plasma membrane, where it inhibits the uptake of cystine, thereby causing ferroptosis. The discovery of ferroptosis-specific markers provides a necessary and important basis for exploring the core issue in the field of ferroptosis: whether ferroptosis occurs under physiological conditions.
[0004] However, there are currently no detection kits and methods related to peroxidation of PRDX3 on the market. Summary of the invention
[0005] In view of this, the present invention develops a kit and method for detecting the activity of ferroptosis marker peroxidation PRDX3.
[0006] The technical solution of the present invention is as follows:
[0007] The first aspect of the present invention provides a new compound, specifically 5-(1-(2-amino-3-mercaptopropylamine)ethyl)-7-(3-(3-ethoxy-4-nitro-5-sulfonyl)-4-(3-ethoxy-4-nitro)-tetrazolyl)naphthalene-1-sulfonate ammonium chloride compound (abbreviated as ENPTD-SH), the molecular formula of the compound is C 32 H 31 N 8 Na 2 O 13 S 3 Cl, and has the following structure:
[0008]
[0009] The compound ENPTD-SH provided by the present invention can serve as a specific substrate of peroxidized PRDX3, and it produces a colored substance under the catalysis of peroxidized PRDX3. Therefore, a system and method for detecting the activity of peroxidized PRDX3 in a sample to be tested can be constructed based on the reaction and using a colorimetric method.
[0010] The second aspect of the present invention provides a method for synthesizing the compound ENPTD-SH, comprising the following steps:
[0011] S1, using sodium 5-(1-aminoethyl)-7-bromonaphthalene-1-sulfonate and tetrazolium borate as raw materials, reacting by Suzuki coupling method to obtain an intermediate compound;
[0012] S2. The intermediate compound and cysteine are reacted in a sodium carbonate-sodium bicarbonate buffer to obtain ENPTD-SH.
[0013] Preferably, in the above synthesis method, step S1 uses dimethyl sulfoxide (DMSO) as solvent and Pd(dppf)Cl 2 The catalyst was used, and the reaction was carried out under nitrogen protection.
[0014] The third aspect of the present invention provides the use of the compound ENPTD-SH in detecting the activity of the ferroptosis marker peroxidation PRDX3, specifically: constructing a detection system containing ENPTD-SH, a reaction buffer and a sample extract to be tested, and ENPTD-SH reacts under the catalysis of peroxidation PRDX3 in the sample extract to be tested to generate a reaction product that makes the detection system appear orange-yellow, namely, 5-(1-(2-amino-3-sulfonic acid propylamine)ethyl)7-((Z)-((E)-(3-ethoxy-4-nitro-5-sulfonylbenzene)diazenyl)(2-(3-ethoxy-4-nitrobenzene) hydrazine)methyl)naphthalene-1-sulfonate new compound (abbreviated as ENPTD-SO 3 H), whose molecular formula is C 32 H 32N 8 Na 3 O 16 S 3 , and the structural formula is as follows:
[0015]
[0016] In the above application of the compound ENPTD-SH of the present invention, the cysteine structure in the compound ENPTD-SH is the site for specific binding of the peroxidized PRDX3 enzyme, and the naphthalene ring and tetrazole structure are color development sites, so the entire compound constitutes an enzyme-specific substrate for the peroxidized PRDX3.
[0017] Preferably, in the above application, the reaction buffer comprises 4-hydroxyethylpiperazineethanesulfonic acid (HEPES), sodium chloride, trehalose, sucrose, bovine serum albumin (BSA), N-methylphenazine methylsulfate (PMS), polyvinylpyrrolidone (PVP30) and polyethylene glycol 20000.
[0018] More preferably, in the above reaction buffer, the HEPES content is 8-12 g / L, the sodium chloride content is 3-5 g / L, the trehalose content is 0.1-0.3 g / L, the sucrose content is 0.5-1.0 g / L, the BSA content is 1.2-2.5 g / L, the PMS content is 4.5-8.2 mg / mL, the PVP30 content is 0.4-0.8 g / L, the polyethylene glycol 20000 content is 1-2 g / L, and the pH of the reaction buffer is 6.5-7.2.
[0019] Preferably, in the above application, the test sample extract is extracted from the test sample by a sample extracting solution, wherein the sample extracting solution comprises potassium dihydrogen phosphate, dipotassium hydrogen phosphate, sucrose, Triton X-100, glycerol, PVP30 and BSA.
[0020] More preferably, in the above-mentioned sample extract, the content of potassium dihydrogen phosphate is 18-22 g / L, the content of dipotassium hydrogen phosphate is 2.95-3.75 g / L, the content of sucrose is 0.8-1.2 g / L, the content of Triton X-100 is 0.5-1.0 mL / L, the content of glycerol is 0.2-0.8 mL / L, the content of PVP30 is 0.8-1.2 g / L, the content of BSA is 2.5-5.2 g / L, and the pH of the sample extract is 7.2-8.0.
[0021] The fourth aspect of the present invention provides a kit for detecting the activity of ferroptosis marker peroxidation PRDX3, which comprises at least the compound ENPTD-SH.
[0022] Preferably, in the above detection kit, reagents such as sample extract, matrix buffer, substrate stock solution, color development auxiliary reagent and standard are included;
[0023] The matrix buffer contained HEPES, sodium chloride, trehalose, sucrose, BSA, PVP30, and polyethylene glycol 20000;
[0024] The substrate stock solution was Tris-HCl buffer containing ENPTD-SH, surfactant NP-40, α-cyclodextrin, and tris(2-carboxyethyl)phosphine hydrochloride (TCEP);
[0025] The color development auxiliary reagent is HEPES buffer containing PMS;
[0026] Standard products are provided by ENPTD-SO 3 H was dissolved in Tris-HCl buffer.
[0027] More preferably, the pH of the matrix buffer is 7.8-8.4, and the contents of the components in the matrix buffer are: HEPES 12-24 g / L, sodium chloride 3-5 g / L, trehalose 1-3 g / L, sucrose 2-4 g / L, BSA 2.5-5.2 g / L, PVP30 0.4-0.8 g / L, and polyethylene glycol 20000 1-2 g / L.
[0028] More preferably, in the above substrate stock solution, the content of ENPTD-SH is 9.2-16.2 mg / mL, the content of NP-40 is 0.5-1.0 mg / mL, the content of α-cyclodextrin is 0.5-1.0 mg / mL, the content of TCEP is 0.2-2.0 mg / mL, the concentration of Tris-HCl buffer is 100 mM, and the pH of the substrate stock solution is 7.4-7.8.
[0029] More preferably, in the above color development auxiliary reagent, the content of PMS is 3.1-6.2 mg / mL, the concentration of HEPES buffer is 50 mM, and the pH of the color development auxiliary reagent is 7.6-8.0.
[0030] More preferably, in the above standard, ENPTD-SO 3 The content of H is 1.85 mg / mL, the concentration of the Tris-HCl buffer is 50 mM, and the pH is 7.4-7.8.
[0031] Based on the detection kit provided by the present invention, the fifth aspect of the present invention provides a method for detecting the peroxidation PRDX3 enzyme activity of a sample, which comprises the following steps:
[0032] (1) Extracting a sample using a sample extracting solution to obtain a sample to be tested;
[0033] (2) Blank wells, standard wells, and assay wells are set on the ELISA plate. Ultrapure water, matrix buffer, substrate stock solution, and colorimetric auxiliary reagent are added to the blank wells, standard substances, colorimetric auxiliary reagent, and matrix buffer are added to the standard wells, and samples to be tested, matrix buffer, substrate stock solution, and colorimetric auxiliary reagent are added to the assay wells;
[0034] (3) Mix well using an ELISA plate mixer;
[0035] (4) Incubate at a specific temperature for a fixed time and measure the OD value at 492 nm using a microplate reader;
[0036] (5) Data processing and calculation of enzyme activity of the samples to be tested.
[0037] The method of the present invention utilizes ENPTD-SH to generate water-soluble ENPTD-SO under the catalysis of peroxidation PRDX3. 3 H and make the reaction system appear orange-yellow, and then the absorbance can be measured by an enzyme reader (the wavelength of the enzyme reader is 492nm for ENPTD-SO 3 H absorption wavelength) properties, according to ENPTD-SO 3 The amount of H generated per unit time was used to measure the activity of the peroxidase PRDX3 enzyme.
[0038] In the above method, the sample in step (1) includes but is not limited to tissue samples and cell samples.
[0039] In the above method, enzyme activity is defined as: the amount of enzyme required to catalyze the substrate to produce 1 μmol of product per gram of tissue or cell protein per minute at a specific temperature is one activity unit; therefore, the data processing and calculation method in step (5) is:
[0040] Fit the curve based on the concentration of the standard and the OD value of the standard: y = ax + b;
[0041] The calculation formula of peroxidation PRDX3 activity in the sample to be tested is as follows:
[0042]
[0043] In the formula, ΔA = measured OD value - blank OD value, a is the slope of the calibration curve, b is the intercept of the calibration curve, T is the reaction time, f is the dilution factor of the sample before testing, C pr The protein concentration of the sample to be tested and the unit is gprot / L.
[0044] Preferably, the specific temperature in step (4) is 25°C-37°C, and the incubation time is 10-30 min; wherein, the OD value measured after incubation at 37°C for 20 min is optimal.
[0045] Compared with the prior art, the beneficial effects of the present invention are:
[0046] (1) The present invention develops a new compound ENPTD-SH that can specifically react with the ferroptosis marker peroxidase PRDX3, which generates a colored product ENPTD-SO under the catalysis of peroxidase PRDX3. 3 H, laid the foundation for the detection of peroxidation PRDX3 enzyme activity;
[0047] (2) Based on ENPTD-SH and ENPTD-SO 3 H. The present invention further successfully constructed an enzyme activity detection system, a detection kit and a detection method for the ferroptosis marker peroxidation PRDX3, and the detection results are reliable.
[0048] (3) The method of the present invention is simple and rapid to operate, and has a wide range of applications, and can be applied to all samples such as animal tissues, cells and microorganisms. BRIEF DESCRIPTION OF THE DRAWINGS
[0049] Figure 1 The technical roadmap for synthesizing the compound ENPTD-SH of the present invention.
[0050] Figure 2 Schematic diagram of the principle of using compound ENPTD-SH as a chromogenic substrate to detect peroxidized PRDX3 enzyme activity.
[0051] Figure 3 This is a standard curve diagram of the method in Example 5. DETAILED DESCRIPTION
[0052] The technical solution of the present invention will be described clearly and completely below in conjunction with the embodiments. It should be understood that the embodiments described herein are only used to illustrate and explain the present invention and are not used to limit the present invention.
[0053] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art to which the present invention belongs. The term "comprises" and any variations thereof in the specification and claims of the present invention are intended to cover non-exclusive inclusions.
[0054] The following examples use 0.01 M NaOH or HCl to adjust the pH. The ferroptosis model samples and the model of knocking out the peroxidation-producing PRDX3 gene used in the following examples are all based on prior art.
[0055] Example 1
[0056] Reference Figure 2 In this example, the compound ENPTD-SH was synthesized, which specifically includes the following steps:
[0057] (1) The intermediate compound A was synthesized by Suzuki coupling method.
[0058] Under nitrogen protection at room temperature, 40.2 mmol of 5-(1-aminoethyl)-7-bromonaphthalene-1-sulfonate solid was dissolved in 60 mL of DMSO, 44.3 mmol of tetrazolyl borate was added, and 0.3 mmol of Pd(dppf)Cl was added. 2 , stirred for 12 hours under nitrogen protection, and detected by LC-MS. After the reaction was complete, a solution of 44.3mmol KOAc solution in 10mL water was added and stirred at room temperature for 3 hours. The reaction was terminated, and extracted with 3×60mL of ethyl acetate. The extract was concentrated to obtain a crude product, and then column chromatography was performed using dichloromethane and acetone as eluents to obtain a pure product of compound A with a yield of 46%.
[0059] (2) Synthesis of compound ENPTD-SH.
[0060] 10 mmol of compound A was added to the reaction bottle, 5 mL of DMSO was added to dissolve and stir, then 11 mmol of cysteine was added, 40 mL of 0.1 M pH = 9.0 sodium carbonate-sodium bicarbonate buffer was added, and the reaction was stirred at room temperature for 12 h, and TLC was used for detection. After the reaction was complete, column chromatography was performed directly, and CH 2 Cl 2 and acetone as eluent to obtain pure ENPTD-SH product with a yield of 85%.
[0061] ENPTD-SHmp 267.8-269.6℃; 1 H NMR (400MHz, DMSO- d 6 ): 8.18-8.15(m, 2H,ArH), 8.03 (d, J = 2.4Hz, 1H, NH), 8.00-7.95 (m, 2H, ArH), 7.93 (s, 1H, ArH), 7.85 (s, 1H, ArH), 7.81-7.82 (m, 2H, ArH), 7.73 (s, 1H, ArH), 7.45 (m, 1H, ArH),7.21(s, 2H, ArH),5.12 (br, 2H, NH 2 ), 4.97 (q, J = 2.4 Hz, 1H, CH), 4.09 (m, 4H, CH 2 ),3.88(m, 1H, CH), 3.19-2.93 (m, 2H,CH 2 ), 1.62 (d, J = 2.4 Hz, 3H, CH3 ), 1.51 (br,1H, SH),1.32 (t, J = 2.4 Hz, 6H, CH 3 ), ppm.HRMS (ESI): calcd forC 32 H 31 N 8 Na 2 O 13 S 3 Cl [M] + , 912.0755; found, 912.0752.
[0062] Example 2
[0063] In this case, the peroxidized PRDX3 was provided by the ferroptosis model sample, and the compound ENPTD-SH was tested for the generation of ENPTD-SO under the catalysis of peroxidized PRDX3. 3 The reaction of H (see Figure 2 ), and also provides a synthesis of ENPTD-SO 3 The specific steps of H method are as follows:
[0064] (1) Obtain extracts of ferroptosis model samples.
[0065] Preparation of sample extract: Take 21.2g of potassium dihydrogen phosphate, 3.05g of potassium dihydrogen phosphate, 1.2g of sucrose, 1.0mL of Triton X-100, 0.8mL of glycerol, 0.8g of PVP30, and 2.8g of BSA; dissolve in 800mL of water, make up to 1000mL, and adjust the pH value to 7.5.
[0066] The ferroptosis model sample was extracted with the above sample extract to obtain an extract.
[0067] (2) Construction of reaction system and product detection.
[0068] Preparation of reaction buffer: weigh 9.5 g HEPES, 3.2 g sodium chloride, 0.15 g trehalose, 0.7 g sucrose, 2.5 g BSA, 4.5 g PMS, 0.8 g PVP30, and 2 g polyethylene glycol 20000; dissolve in 800 mL water, make up to 1000 mL, and adjust the pH to 7.0.
[0069] 3.6mmol ENPTD-SH was added to the reaction bottle, 10mL reaction buffer was added, and then 1mL model sample extract was added. The reaction was carried out at 25℃ and detected by TLC. After the reaction was complete, column chromatography was performed directly. CH 2 Cl 2 and acetone as eluent to obtain ENPTD-SO3 H pure product, yield 90%.
[0070] ENPTD-SO 3 Hmp 287.3-296.8℃; 1 H NMR (400MHz, DMSO- d 6 ):8.56 (d, J = 7.2Hz, 1H, ArH), 8.25 (d, J = 7.2Hz, 1H, ArH), 8.18 (d, J = 7.2Hz,1H, ArH), 8.06 (br, 1H,NH), 7.81-7.82 (m, 2H, ArH), 7.73 (d, J = 7.2Hz, 1H, ArH), 7.62 (d, J = 2.4Hz, 1H, ArH), 7.13 (d, J = 2.4Hz, 1H, ArH), 7.06 (br, 1H, NH), 6.76 (m, 1H, ArH), 6.44 (d, J = 2.4Hz,1H, ArH), 5.11 (br, 2H, NH 2 ), 4.97 (q, J = 2.4Hz, 1H, CH), 4.09-3.79 (m,6H, CH 2 ), 3.63 (m, 1H, CH), 2.01 (br,1H, OH), 1.61 (d, J = 2.4Hz, 3H, CH 3 ), 1.32 (t, J = 2.4Hz, 6H, CH 3 ), ppm. HRMS (ESI): calcd forC 32 H 32 N 8 Na 3 O 16 S 3 [M] + , 926.0945;found, 912.0943.
[0071] Example 3
[0072] This example further verifies the specificity of ENPTD-SH as a chromogenic substrate for peroxidized PRDX3 through comparative experiments, which specifically include the following steps:
[0073] (1) Dissolve ENPTD-SH in 1 mL DMSO and add 15 mL substrate buffer to prepare substrate application solution; the substrate buffer is prepared as follows: weigh 8.8 g HEPES, 5 g sodium chloride, and 4.5 g PMS, dissolve them in 800 mL water, make up to 1000 mL, and adjust the pH to 7.2.
[0074] (2) Take ENPTD-SO 3 H was dissolved in Tris-HCl buffer to prepare ENPTD-SO 3 H standard, specifically: weigh 1.85 mg ENPTD-SO 3 H, dissolved in 4 mL 50 mM pH = 7.6 Tris-HCl buffer and mixed well.
[0075] (3) Take normal samples, ferroptosis model samples, and models in which the PRDX3 gene is knocked out during ferroptosis modeling to produce peroxidation, and extract them with 0.1 mL of sample extract solution, respectively. The extract is used as a specificity verification sample. The sample extract solution used in this example is prepared as follows: weigh 22 g of potassium dihydrogen phosphate, 3.75 g of potassium dihydrogen phosphate, 1.2 g of sucrose, 1.0 mL of Triton X-100, 0.2 mL of glycerol, 0.8 g of PVP30, and 2.8 g of BSA; dissolve in 800 mL of water, make up to 1000 mL, and adjust the pH value to 7.6.
[0076] (4) Design a control experiment using the above-mentioned verification samples, substrate application solution, substrate buffer solution, and standard solution. The specific steps are as follows:
[0077] ① Blank wells, standard wells and assay wells are set on the ELISA plate; sample extract and substrate application solution are added to the blank wells, standard substances and substrate buffer are added to the standard wells, and verification samples and substrate application solution are added to the assay wells.
[0078] ② Use an ELISA plate mixer to mix for 60 seconds;
[0079] ③ Incubate at 37°C for 30 min and measure OD value at 492 nm using an enzyme reader; specific data are shown in Table 1.
[0080] Table 1 OD values under different validation sample conditions
[0081]
[0082] The data show that normal samples, model samples in which the gene for producing overoxidized PRDX3 was knocked out during ferroptosis modeling, and blank wells did not show color, indicating that the detection system did not react, that is, the sample extract did not contain substances that cause the substrate to show color; the extracts of the ferroptosis model samples showed color, while the extracts of the model samples in which the gene for producing overoxidized PRDX3 was knocked out during ferroptosis modeling did not show color, which fully demonstrates that the chromogenic substrate ENPTD-SH is specific to overoxidized PRDX3.
[0083] Example 4
[0084] This example provides a ferroptosis marker peroxidation PRDX3 activity detection kit, which specifically includes the following reagents:
[0085] The sample extract was prepared as follows: 1.85 g potassium dihydrogen phosphate, 0.35 g potassium dihydrogen phosphate, 0.1 g sucrose, 0.1 mL Triton X-100, 0.08 mL glycerol, 0.1 g PVP30, and 0.3 g BSA were weighed and the volume was made up to 100 mL. After adjusting the pH value to 7.8, 50 mL of sample extract was prepared, and 2 bottles were placed in a dark place at 4°C.
[0086] The matrix buffer solution was prepared as follows: 1.8 g HEPES, 0.4 g sodium chloride, 0.2 g trehalose, 0.2 g sucrose, 0.28 g BSA, 0.06 g PVP30, and 0.16 g polyethylene glycol 20000 were weighed, dissolved in water, and the volume was adjusted to 100 mL. After adjusting the pH value to 8.0, 50 mL of the matrix buffer solution was prepared, 2 bottles, and stored at 4°C away from light.
[0087] The substrate stock solution was prepared as follows: 120 mg ENPTD-SH, 6 mg NP-40, 5 mg α-cyclodextrin, and 2 mg TCEP were weighed and dissolved in 10 mL 100 mM Tris-HCl, pH = 7.4 to prepare the substrate stock solution, 5 mL of which was taken into a bottle and stored at 4°C away from light.
[0088] The color development auxiliary reagent is prepared as follows: 24 mg of PMS is weighed and dissolved in 5 mL of 50 mM HEPES buffer, pH = 7.8, to prepare a color development auxiliary reagent, 4 mL of which is put into a bottle and stored at -20°C away from light;
[0089] The standard product is prepared as follows: weigh 9.25 mg ENPTD-SO 3 H was dissolved in 5 mL of 50 mM Tris-HCl buffer, pH = 7.8, to prepare a standard. 2 mL of it was placed in 2 bottles and stored at -20°C in the dark.
[0090] Example 5
[0091] This example provides a method for detecting the activity of peroxidase PRDX3 using the kit of the present invention, which specifically includes the following steps:
[0092] (1) Sample extraction and processing.
[0093] For tissue samples, the processing method is as follows: accurately weigh the tissue, add sample extract at a ratio of weight (g): volume (mL) = 1:9, homogenize under ice water bath conditions, centrifuge at 1000×g for 10 minutes, take the supernatant, and then dilute it with sample extract to different concentrations for preliminary experiments.
[0094] For cell samples, the processing method includes the following two steps:
[0095] Collection of cultured cells: ① For cells cultured in suspension, the precipitated cells can be directly collected by centrifugation (200×g, centrifugation for 10 min, discard the supernatant and keep the precipitated cells); ② For cells cultured on the wall, aspirate the supernatant, scrape the cells directly with a cell scraper, or digest them with 0.25% trypsin at room temperature for 2-3 min, add culture medium to terminate digestion, use a micropipette to gently blow, aspirate all the liquid into an EP tube, centrifuge at 200×g for 10 min, discard the supernatant, keep the precipitated cells, add 1mL PBS and gently blow, centrifuge again at 200×g for 10 min, discard the supernatant, and keep the precipitated cells for later use.
[0096] Disruption of cultured cells: ① Grinding and disintegration, that is, adding a certain amount (10 6 ② Add 0.3-0.5 mL of sample extract to each cell), grind with a manual glass homogenizer in an ice-water bath for 3-5 min; ② Ultrasonic disruption, that is, add a certain amount (according to 10 6 Add 0.3-0.5mL of sample extract to each cell), and use an ultrasonic cell disruptor to disrupt the cells. The power is 300W, and the cells are placed in an ice water bath. Ultrasonication is performed every 3-5s, with an interval of 4 times (each interval is about 30s).
[0097] The total protein concentration of the extracted tissue and cell samples to be tested must be measured. In this example, the BCA method is used to measure the protein concentration.
[0098] (2) Test (room temperature 25-30℃).
[0099] ① Set up blank wells, standard wells, and assay wells on the ELISA plate (as shown in Table 2 in this example):
[0100] Table 2 ELISA plate settings
[0101]
[0102] Note: AH: blank wells, standard wells; S1-S80: measurement wells.
[0103] Among them, blank wells: add 20μL ultrapure water, 200μL matrix buffer, 40μL substrate stock solution and 20μL color development auxiliary reagent; standard wells: add 20μL standards of different concentrations, 240μL matrix buffer and 20μL color development auxiliary reagent; measurement wells: add 20μL test sample, 200μL matrix buffer, 40μL substrate stock solution and 20μL color development auxiliary reagent.
[0104] ② Use an ELISA plate mixer to mix for 30 seconds.
[0105] ③Incubate at 37℃ for 20min and measure OD value at 492nm using an enzyme reader.
[0106] (3) Calculate the peroxidation PRDX3 activity according to the following formula:
[0107]
[0108] Where, ΔA = measured OD value - blank OD value, a: slope of the calibration curve, b: intercept of the calibration curve, T: reaction time, f: dilution factor of the sample before testing, C pr : Protein concentration of the sample to be tested, gprot / L; U definition: The amount of enzyme required to catalyze the substrate to produce 1 μmol of product per gram of tissue or cell protein per minute at 37°C is one activity unit.
[0109] Based on step (2), it is common knowledge in the art to establish a standard curve between the concentration of the standard substance and the OD value, so the construction of the standard curve will not be described in detail here. Under the conditions of this example, the standard curve data are shown in Tables 3 and Figure 3 , and the fitting curve formula is y = 0.1156x + 0.0072, R² = 0.9932.
[0110] Table 3. Curve data
[0111]
[0112] Example 6
[0113] Based on the kit of Example 4 and the detection method of Example 5, the present invention detects the following four samples: rat liver tissue (normal group), rat liver tissue (ferroptosis model group), 293T cells (normal group), and 293T cells (ferroptosis model group). The detection results are shown in Table 4.
[0114] Table 4 Sample enzyme activity test results
[0115]
[0116] The results of sample enzyme activity test showed that the activity of peroxidized PRDX3 could not be detected in the samples of the normal group, while the activity of peroxidized PRDX3 could be detected in the samples of the ferroptosis model group.
[0117] The raw materials listed in the present invention, as well as the upper and lower limits and interval values of the raw materials of the present invention, and the upper and lower limits and interval values of the process parameters can all realize the present invention, and the embodiments are not listed one by one here.
[0118] In summary, the compounds ENPTD-SH and ENPTD-SO designed and developed according to the present invention are 3 H. The present invention successfully established a kit and method for detecting the activity of the ferroptosis marker peroxidase PRDX3, and the detection sensitivity is high and the detection results are reliable, which is of great significance for the study of the mechanism of ferroptosis and the development of ferroptosis-related drugs.
[0119] It should be noted that the above embodiments are only part of the embodiments of the present invention rather than all the embodiments, and are only used to illustrate the technical solution of the present invention rather than to limit it. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.
Claims
1. A compound, It is characterized in that The compound is ENPTD-SH, which has the following structure: 。 2. Use of the compound according to claim 1 in detecting the activity of the ferroptosis marker peroxidation PRDX3, wherein the use is not for the purpose of diagnosis and treatment of diseases.
3. The use according to claim 2, It is characterized in that ENPTD-SH, as a chromogenic substrate, reacts with peroxidized PRDX3 to generate a water-soluble compound, ENPTD-SO 3 H; the compound ENPTD-SO 3 The structural formula of H is as follows: 。 4. A kit for detecting the activity of ferroptosis marker peroxidation PRDX3, It is characterized in that The compound ENPTD-SH according to claim 1 and the compound ENPTD-SO according to claim 3 are included. 3 H.
5. The ferroptosis marker peroxidation PRDX3 activity detection kit according to claim 4, It is characterized in that It includes sample extract, matrix buffer, substrate stock solution, color development auxiliary reagent and standard substance; among which, The sample extract solution comprises potassium dihydrogen phosphate, dipotassium hydrogen phosphate, sucrose, Triton X-100, glycerol, PVP30 and BSA; The matrix buffer contains HEPES, sodium chloride, trehalose, sucrose, BSA, PVP30, and polyethylene glycol 20000; The substrate stock solution is a Tris-HCl buffer containing ENPTD-SH, surfactant NP-40, α-cyclodextrin, and TCEP; The color development auxiliary reagent is a HEPES buffer containing PMS; The standard is provided by ENPTD-SO 3 H was dissolved in Tris-HCl buffer.
6. The ferroptosis marker peroxidation PRDX3 activity detection kit according to claim 5, It is characterized in that The pH of the sample extract is 7.2-8.0, and the contents of its components are: potassium dihydrogen phosphate 18-22 g / L, dipotassium hydrogen phosphate 2.95-3.75 g / L, sucrose 0.8-1.2 g / L, Triton X-100 0.5-1.0 mL / L, glycerol 0.2-0.8 mL / L, PVP30 0.8-1.2 g / L, BSA 2.5-5.2 g / L; The pH of the matrix buffer is 7.8-8.4, and the contents of its components are: HEPES 12-24 g / L, sodium chloride 3-5 g / L, trehalose 1-3 g / L, sucrose 2-4 g / L, BSA 2.5-5.2 g / L, PVP30 0.4-0.8 g / L, polyethylene glycol 20000 1-2 g / L; The pH of the substrate stock solution is 7.4-7.8, and the contents of its components are: ENPTD-SH 9.2-16.2 mg / mL, NP-40 0.5-1.0 mg / mL, α-cyclodextrin 0.5-1.0 mg / mL, TCEP 0.2-2.0 mg / mL, and the concentration of Tris-HCl buffer is 100 mM; The pH of the color development auxiliary reagent is 7.6-8.0, the content of PMS is 3.1-6.2 mg / mL, and the concentration of HEPES buffer is 50 mM; ENPTD-SO in the standard 3 The content of H was 1.85 mg / mL, and the concentration of Tris-HCl buffer was 50 mM, with a pH of 7.4-7.
8.
7. A method for detecting the activity of ferroptosis marker peroxidase PRDX3 in a sample, It is characterized in that The method is not intended for the diagnosis and treatment of a disease. The method uses the kit described in claim 5 or 6 for detection, and specifically comprises the following steps: (1) Extracting the sample with a sample extracting solution to obtain a sample to be tested; (2) Blank wells, standard wells, and assay wells are set on the ELISA plate. Ultrapure water, matrix buffer, substrate stock solution, and colorimetric auxiliary reagent are added to the blank wells, standard substances, colorimetric auxiliary reagent, and matrix buffer are added to the standard wells, and samples to be tested, matrix buffer, substrate stock solution, and colorimetric auxiliary reagent are added to the assay wells; (3) Mix well using an ELISA plate mixer; (4) Incubate at temperature W for time T and measure OD value at 492 nm using a microplate reader; (5) Data processing and calculation of enzyme activity of the samples to be tested.
8. The method according to claim 7, It is characterized in that The sample in step (1) is a tissue sample and / or a cell sample.
9. The method according to claim 7, It is characterized in that The enzyme activity in step (5) is defined as: at temperature W, 1 μmol ENPTD-SH is catalyzed per gram of protein per minute to produce 1 μmol ENPTD-SO 3 The amount of enzyme required for H is one activity unit; and step (5) uses the following formula to calculate the activity of peroxidized PRDX3 in the sample to be tested: In the formula, ΔA = measured OD value - blank OD value, a is the slope of the calibration curve, b is the intercept of the calibration curve, T is the reaction time, f is the dilution factor of the sample before testing, C pr is the protein concentration of the sample to be tested and the unit is gprot / L.
10. The method according to claim 7, It is characterized in that In step (4), the W temperature is 25°C-37°C, and the T time is 10-30 min.
